Stay updated on Subcutaneous Atezolizumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Subcutaneous Atezolizumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Subcutaneous Atezolizumab in NSCLC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    A new site revision entry Revision: v3.3.3 was added. The items 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' were removed.
    Difference
    0.2%
    Check dated 2025-12-23T08:29:05.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The Record History shows an addition of Revision: v3.3.2 and a deletion of Revision: v3.3.1 in the study record history. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T17:26:43.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    Added a new history entry: Revision v3.3.1. The previous Revision v3.2.0 entry has been removed.
    Difference
    0.1%
    Check dated 2025-11-24T14:36:03.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The government funding notice/banner about operating status was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.8%
    Check dated 2025-11-17T06:47:03.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    The history shows multiple updates to study status and recruitment status across versions, reflecting changes in trial activity and enrollment over time.
    Difference
    0.1%
    Check dated 2025-11-03T01:16:16.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Upgrade to v3.2.0 with a government operating-status notice and links to status pages; removes the previous v3.1.0 reference.
    Difference
    13%
    Check dated 2025-10-05T10:05:49.000Z thumbnail image

Stay in the know with updates to Subcutaneous Atezolizumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Subcutaneous Atezolizumab in NSCLC Clinical Trial page.